BackNANO MRNA ,Ltd. Overview

NANO MRNA ,Ltd. Current Cash

Latest current cash for 4571.T: $4.2B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4.22B
↑ 164.15% YoYΔ $2.62B vs prior year quarter

Peer trimmed avg / median

Loading

NANO MRNA ,Ltd. Current Cash History

Loading

NANO MRNA ,Ltd. vs. peers: Current Cash Comparison

Loading

NANO MRNA ,Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NANO MRNA ,Ltd. (4571.T) FAQ

NANO MRNA ,Ltd. (4571.T) currently reports a current cash of $4.2B as of June 2026. That compares with $1.6B in the prior-year period — up 164.2% year over year. Use the charts on this page to explore NANO MRNA ,Ltd.'s current cash history and peer comparisons.

NANO MRNA ,Ltd.'s current cash increased from $1.6B to $4.2B — a 164.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NANO MRNA ,Ltd. reported $4.2B in current cash as of June 2026. That compares with $1.6B in the prior-year period — up 164.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $4.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NANO MRNA ,Ltd., and consider following 4571.T for alerts when major investors trade the stock.

NANO MRNA ,Ltd. is classified in the Healthcare sector. On current cash, it currently shows $4.2B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4571.T with unrelated industries.